SKIP TO CONTENT
about abbott
contact
International | eng
Country Language
International | eng
Country Language

Confirm Rx

Insertable Cardiac Monitor with SharpSense Technology

Patient Compliance

Experience Enhanced Patient Compliance

The myMerlin™ mobile app ensures patients are connected when it matters most.

Remote monitoring via smartphone connectivity with an easy-to-use app encourages patient compliance with less disruption to their daily lives. Data is proactively transmitted by the myMerlin mobile app per a schedule set by your clinic.

~ai-f884303a-ba9c-4196-8b4e-ee9342788fa2_

The myMerlin mobile app enhancement includes updates to the patient notifications, helping patients stay connected while improving compatibility with the new iOS and Android‡ operating systems. The app automatically informs patients of successful device checks and clinic-scheduled transmissions or notifies them when one has been missed.

Additional improvements to the pairing process and transmission capabilities help make the fastest and most reliable ICM remote monitvoring solution even better.2 The intuitive interface engages patients with the familiarity of their smartphone.

Graphic showing statistic of 97% of patients compliant with myMerlin mobile app

The myMerlin mobile app encourages patient engagement, allowing patients to:

  • Better describe their symptoms with keywords (e.g., fainting, fluttering) to give you insights for a confident diagnosis.
  • Depending on how you manage your clinic’s settings, patients may be able to send a transmission while experiencing symptoms without having to wait for a nightly sync.
  • View their own transmissions and symptom history so they don’t need to contact you to confirm successful transmissions.

Patients enjoy peace of mind knowing they will be alerted if:

  • The device is not checked daily
  • The transmission is not sent to the clinic
Phone screen displaying the myMerlin app

Receive Patient Data Faster with the Confirm Rx ICM.3

Confirm Rx ICM data from patient-initiated transmission is approximately

20X FASTER

than Reveal LINQ‡ ICM.3

Mean time to patient-initiated transmission is significantly faster with Confirm Rx ICM3

Abbott Confirm Rx ICM

Medtronic Reveal LINQ‡ ICM

P-value (P<0.0001)

24 ± 103 MIN.3

475 ± 426 MIN.3

Manuals & Technical Resources

Manuals & Technical Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.

References

  1. Piorkowski C, et al. Early real-world adoption of mobile remote monitoring using the Confirm Rx Insertable Cardiac Monitor. Poster presented at: APHRS; 2018.
  2. Yokokawa M, Ip R, Azad R, et al. Accuracy of arrhythmia detection using implantable cardiac monitor: a comparison between Reveal LINQ and Confirm Rx. HRS Poster; May 2019; Sparrow Clinical Research Institute, Michigan State University, Lansing, MI.
  3. Ip J, Jaffe B, Castellani M, et al. Arrhythmia Detection in Implantable Cardiac Monitor Randomized Clinical Trial Comparing Reveal LINQ and Confirm Rx. PACE. Sept. 24, 2020. https://doi.org/10.1111/pace.14076

MAT-2012209 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2023 Abbott. All Rights Reserved.

MAT-2001111 v5.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

MAT-2305078 v1.0